Nature of Neurological Complications and Outcome After Surgery for Type A Aortic Dissection
Language English Country United States Media print-electronic
Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
38458584
DOI
10.1016/j.amjcard.2024.03.001
PII: S0002-9149(24)00167-X
Knihovny.cz E-resources
- Keywords
- aortic dissection, global cerebral ischemia, stroke, type A aortic dissection,
- MeSH
- Aortic Aneurysm, Thoracic * surgery mortality MeSH
- Aortic Dissection * surgery mortality MeSH
- Hemorrhagic Stroke epidemiology MeSH
- Ischemic Stroke * epidemiology MeSH
- Brain Ischemia etiology epidemiology MeSH
- Middle Aged MeSH
- Humans MeSH
- Survival Rate trends MeSH
- Hospital Mortality * trends MeSH
- Postoperative Complications * epidemiology MeSH
- Prognosis MeSH
- Registries * MeSH
- Retrospective Studies MeSH
- Risk Factors MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Europe epidemiology MeSH
Surgery for type A aortic dissection (TAAD) is frequently complicated by neurologic complications. The prognostic impact of neurologic complications of different nature has been investigated in this study. The subjects of this analysis were 3,902 patients who underwent surgery for acute TAAD from the multicenter European Registry of Type A Aortic Dissection (ERTAAD). During the index hospitalization, 722 patients (18.5%) experienced stroke/global brain ischemia. Ischemic stroke was detected in 539 patients (13.8%), hemorrhagic stroke in 76 patients (1.9%) and global brain ischemia in 177 patients (4.5%), with a few patients having had findings of more than 1 of these conditions. In-hospital mortality was increased significantly in patients with postoperative ischemic stroke (25.6%, adjusted odds ratio [OR] 2.422, 95% confidence interval [CI] 1.825 to 3.216), hemorrhagic stroke (48.7%, adjusted OR 4.641, 95% CI 2.524 to 8.533), and global brain ischemia (74.0%, adjusted OR 22.275, 95% CI 14.537 to 35.524) compared with patients without neurologic complications (13.5%). Similarly, patients who experienced ischemic stroke (46.3%, adjusted hazard ratio [HR] 1.719, 95% CI 1.434 to 2.059), hemorrhagic stroke (62.8%, adjusted HR 3.236, 95% CI 2.314 to 4.525), and global brain ischemia (83.9%, adjusted HR 12.777, 95% CI 10.325 to 15.810) had significantly higher 5-year mortality than patients without postoperative neurologic complications (27.5%). The negative prognostic effect of neurologic complications on survival vanished about 1 year after surgery. In conclusion, postoperative ischemic stroke, hemorrhagic stroke, and global cerebral ischemia increased early and midterm mortality after surgery for acute TAAD. The magnitude of risk of mortality increased with the severity of the neurologic complications, with postoperative hemorrhagic stroke and global brain ischemia being highly lethal complications.
Cardiac Surgery Molinette Hospital University of Turin Turin Italy
Cardiothoracic Department Azienda Sanitaria Universitaria Friuli Centrale Udine Italy
Cardiovascular Surgery Department University Hospital Gregorio Marañón Madrid Spain
Department of Cardiac Surgery Centre Cardiologique du Nord de Saint Denis Paris France
Department of Cardiac Surgery Centre Hospitalier Annecy Genevois Epagny Metz Tessy France
Department of Cardiac Surgery Glenfield Hospital Leicester United Kingdom
Department of Cardiac Surgery Ziekenhuis Oost Limburg Genk Belgium
Department of Cardiothoracic Surgery University Hospital Muenster Muenster Germany
Department of Cardiovascular Surgery Hospital Clínic de Barcelona University of Barcelona Spain
Department of Cardiovascular Surgery University Heart and Vascular Center Hamburg Hamburg Germany
Department of Medicine South Karelia Central Hospital University of Helsinki Lappeenranta Finland
Department of Thoracic and Cardiovascular Surgery University of Franche Comte Besancon France
Division of Cardiac Surgery University of Verona Medical School Verona Italy
Heart and Lung Center Helsinki University Hospital University of Helsinki Helsinki Finland
LMU University Hospital Ludwig Maximilian University Munich Germany
References provided by Crossref.org
ClinicalTrials.gov
NCT04831073